RxSight, Inc. (RXST)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, RxSight, Inc. reported revenue of $134.48M, down 3.9% from the prior year. The company ran a net loss, with a net margin of -29.0% and a gross margin of 76.6%. It held $311.81M in total assets against $36.13M in total liabilities.
Key ratios (FY2025)
76.6%
Gross margin
-35.8%
Operating margin
-29.0%
Net margin
-14.1%
Return on equity
-3.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $134.48M | $139.93M | $89.08M | $49.01M | $22.59M | $14.68M | — |
| Cost of Revenue | $31.47M | $40.98M | $35.31M | $27.68M | $18.08M | $12.97M | — |
| Gross Profit | $103.01M | $98.94M | $53.77M | $21.33M | $4.52M | $1.71M | — |
| Operating Income | -$48.19M | -$36.86M | -$50.09M | -$63.32M | -$52.79M | -$35.41M | — |
| Net Income | -$38.94M | -$27.45M | -$48.61M | -$66.76M | -$48.69M | $27.57M | — |
| EPS (Diluted) | $-0.95 | $-0.71 | $-1.41 | $-2.41 | $-3.57 | $0.15 | — |
| Total Assets | $311.81M | $318.56M | $182.55M | $150.16M | $192.72M | $100.68M | — |
| Total Liabilities | $36.13M | $37.33M | $22.19M | $60.26M | $54.48M | $44.91M | — |
| Shareholders' Equity | $275.68M | $281.24M | $160.36M | $89.90M | $138.24M | -$430.59M | -$419.81M |
| Cash & Equivalents | $19.95M | $16.71M | $9.69M | $11.83M | $24.36M | $13.99M | — |
| Operating Cash Flow | -$15.51M | -$16.95M | -$41.59M | -$58.85M | -$44.71M | -$35.20M | — |
| Capital Expenditures | $3.83M | $5.44M | $4.81M | $2.39M | $1.94M | $2.54M | — |
| Shares Outstanding | 40.85M | 38.87M | 34.46M | 27.66M | 13.63M | 5.53M | — |